trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Fluorination of pharmaceuticals improves metabolic stability and membrane permeability

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Fluorination of pharmaceuticals improves metabolic stability and membrane permeability?

Yes. Multiple studies and reviews confirm that strategic fluorination of pharmaceutical compounds enhances their metabolic stability and pharmacokinetic profiles.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently support the claim that fluorination improves metabolic stability in drug design, citing specific mechanisms and examples across peptides and small molecules. No papers refute the claim.

Evidence for · 5
2008
This study demonstrates that fluorinated peptide analogues display significantly higher proteolytic and metabolic stability while retaining efficacy.
Get citation
Meng, H., Krishnaji, S. T., Beinborn, M., & Kumar, K. (2008). Influence of Selective Fluorination on the Biological Activity and Proteolytic Stability of Glucagon-like Peptide-1. doi.org. https://doi.org/10.1021/jm8008579

See more details
More for · 4
2022
The research shows that gem-difluorination of aliphatic compounds successfully improves their metabolic stability.
Get citation
Holovach, S., Melnykov, K. P., Skreminskiy, A., Herasymchuk, M. V., Tavlui, O., Aloshyn, D. D., Borysko, P. O., Rozhenko, A., Ryabukhin, S., Volochnyuk, D., & Grygorenko, O. (2022). Effect of gem-difluorination on the key physicochemical properties relevant to medicinal chemistry: the case of functionalized cycloalkanes.. doi.org. https://doi.org/10.1002/chem.202200331

2014
Targeted fluorination of a nonsteroidal anti-inflammatory drug at metabolically labile sites successfully slows down oxidation and prolongs metabolic half-life.
Get citation
Shaughnessy, M. J., Harsanyi, A., Li, J., Bright, T., Murphy, C., & Sandford, G. (2014). Targeted Fluorination of a Nonsteroidal Anti‐inflammatory Drug to Prolong Metabolic Half‐Life. doi.org. https://doi.org/10.1002/cmdc.201300490

2026
This review highlights how the incorporation of fluorine and fluorinated motifs improves metabolic profiles and pharmacokinetic properties in drug molecules.
Get citation
P, B., TA, T., & RA, A. (2026). Metabolic Stability of Fluorinated Small Molecules: A Physical Organic Chemistry Perspective.. doi.org. https://doi.org/10.1021/acs.jmedchem.5c02359

2026
This study notes that fluorine incorporation significantly influences physicochemical properties including metabolic stability and overall bioavailability.
Get citation
D, B. T., M, D., N, I., C, S., & L, S. (2026). Halogen-Containing Drugs in 2025: A Record Year for the Therapeutic Use and Synthesis of FDA-Approved Small Molecules.. doi.org. https://doi.org/10.3390/biom16030381

Related receipts

What does the evidence say?

The retrieved papers consistently support the claim that fluorination improves metabolic stability in drug design, citing specific mechanisms and examples across peptides and small molecules. No papers refute the claim.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8604 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work